Argmann Carmen A, Houten Sander M, Zhu Jun, Schadt Eric E
Department of Genetics and Genomic Sciences and Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Box 1498, New York, NY 10029, USA.
Department of Genetics and Genomic Sciences and Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Box 1498, New York, NY 10029, USA.
Cell Metab. 2016 Jan 12;23(1):13-26. doi: 10.1016/j.cmet.2015.11.012. Epub 2015 Dec 17.
Inborn errors of metabolism (IEM) are not unlike common diseases. They often present as a spectrum of disease phenotypes that correlates poorly with the severity of the disease-causing mutations. This greatly impacts patient care and reveals fundamental gaps in our knowledge of disease modifying biology. Systems biology approaches that integrate multi-omics data into molecular networks have significantly improved our understanding of complex diseases. Similar approaches to study IEM are rare despite their complex nature. We highlight that existing common disease-derived datasets and networks can be repurposed to generate novel mechanistic insight in IEM and potentially identify candidate modifiers. While understanding disease pathophysiology will advance the IEM field, the ultimate goal should be to understand per individual how their phenotype emerges given their primary mutation on the background of their whole genome, not unlike personalized medicine. We foresee that panomics and network strategies combined with recent experimental innovations will facilitate this.
先天性代谢缺陷(IEM)与常见疾病并无不同。它们常常表现为一系列疾病表型,这些表型与致病突变的严重程度相关性较差。这对患者护理产生了极大影响,并揭示了我们在疾病修饰生物学知识方面的根本差距。将多组学数据整合到分子网络中的系统生物学方法显著提高了我们对复杂疾病的理解。尽管IEM具有复杂性,但采用类似方法来研究IEM的情况却很少见。我们强调,现有的源自常见疾病的数据集和网络可以重新利用,以在IEM中产生新的机制性见解,并有可能识别候选修饰因子。虽然理解疾病病理生理学将推动IEM领域的发展,但最终目标应该是了解每个个体在其全基因组背景下,鉴于其原发性突变,其表型是如何出现的,这与个性化医疗并无不同。我们预见,泛组学和网络策略与近期的实验创新相结合将有助于实现这一目标。